PATENT CLAIM ANALYSIS

Application Number: 16159282
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-02
Patent Classification: ["424", "134100"]

Abstract:
The present invention provides methods for treating angiogenic eye disorders by sequentially administering multiple doses of a VEGF antagonist to a patient. The methods of the present invention include the administration of multiple doses of a VEGF antagonist to a patient at a frequency of once every 8 or more weeks. The methods of the present invention are useful for the treatment of angiogenic eye disorders such as age related macular degeneration, diabetic retinopathy, diabetic macular edema, central retinal vein occlusion, branch retinal vein occlusion, and corneal neovascularization.

Claim (Index 42):
The method of  claim 39 , wherein the angiogenic eye disorder is diabetic macular edema.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 97.0
- Lexical Diversity: 1.77778
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13940370', '15471506', '14972560', '11998709', '11089803']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7991158872734407
- 35 USC 102 Novelty (BERT): 0.5553854050242414
- Combined Prediction Score: 0.7747428390485208
- Mean Citation Score: 380.816582
- Max Citation Score: 456.2243
- Similarity Product: 291.9514032444239

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test